Rapid Mental Energy - RME3
- Sharpens working memory‡
- Supports alertness‡
- Supports cognitive performance‡
- Two clinically backed ingredients
- Not known to interfere with sleep
- Can be safely used with caffeine
Indications
- Ages 18 and up
- As-needed support for alertness and working memory‡
Suggested Use
As a dietary supplement, take 1 capsule as needed, with or between meals, or as directed by a health professional.
Verifiable Science
Rapid Mental Energy combines clinically studied extracts, Alpinia galanga (enXtra) and American ginseng (Cereboost®), to support alertness and sharpen working memory.1-5 In a randomized, double-blind, placebo-controlled crossover study, enXtra significantly increased alertness scores from baseline values at 1 hour, 3 hours and 5 hours after a single 300 mg dose.1 Alertness scores were significantly greater in the enXtra group compared to placebo (p=0.04) at 3 hours post-dose. While enXtra supports alertness and attention network function (the ability to direct mental resources to a specific task), Cereboost® provides fast-acting support for acute visuospatial and verbal short-term (working) memory.1-5 in a study of 52 healthy middle-aged adults, Cereboost® (200 mg) improved working memory 3 hours after a single dose.2 In a randomized controlled clinical trial of 61 healthy young adults, daily use of Cereboost® (200 mg) improved working memory and attention.3 In a randomized, double-blind crossover trial of 32 healthy volunteers, a single dose of Cereboost® (200 mg) improved working memory (immediate word recall and visuo-spatial information retrieval) at 1 hour post-dose and was sustained over a 6 hour testing period.4 The ginsenosides in Cereboost® support cholinergic neurotransmission in the hippocampus and prefrontal cortex, key brain regions involved in learning and memory.5 ‡
References
- Srivastava S, Mennemeier M, Pimple S. J Am Coll Nutr. 2017 Nov-Dec;36(8):631-639. doi: 10.1080/07315724.2017.1342576.
- Bell L, Whyte A, Duysburgh C, et al. Eur J Nutr. 2022 Feb;61(1):413-428.
- Ossoukhova A, Owen L, Savage K, et al. Human Psychopharmacol. 2015;30(2):108–122.
- Scholey A, Ossoukhova A, Owen L, et al. Psychopharmacology. 2010;212(3):345–356.
- Shin K, Guo H, Cha Y, et al. Regul Toxicol Pharmacol. 2016 Jul;78:53-8.
